Date of this Version
Despite ethical concerns about gene patents, virtually no empirical evidence exists to support claims about either positive or negative effects, and extremely little is known about the intellectual property protection strategies of firms and universities. This article discusses the results of a pilot study to examine patenting and licensing philosophies, policies, and practices of different types of institutions and to describe the contractual conditions for licensing DNA sequence inventions.
Henry, M. R., Cho, M. K., Weaver, M. A., & Merz, J. F. (2003). A Pilot Survey on the Licensing of DNA Inventions. Retrieved from http://repository.upenn.edu/bioethics_papers/50
Date Posted: 21 May 2007
This document has been peer reviewed.